All blog posts
Total 34 results for
Showing 12 out of 34 results
22 January 2026
China’s Merger Review Guidelines: A Comparative Look against the EU Framework (Non-Horizontal)
14 August 2025
China’s First Unwinding Order: SAMR Blocks Completed Below-Threshold Pharma Deal
17 July 2025
China Releases the 2025 Anti-Unfair Competition Law
11 November 2024
Class actions radar: Scanning global trends and risks
13 September 2024
Shaping the future of Chinese competition policy: Insights into SAMR's draft rules for calculating fines for gun-jumping
10 November 2023
#FDIFriday: HSF Global FDI podcast - the Thai FDI regime
27 October 2023
#FDIFriday: HSF Global FDI podcast – the Chinese and Indonesian FDI regimes
25 April 2023
Highlights from the Amendments to Four Substantive Regulations in China
09 February 2023
Competition law developments in the pharma sector – 2022 round-up and what to expect in 2023
10 October 2022
A new milestone for Hong Kong's Competition Commission: First enforcement proceedings in relation to resale price maintenance
05 July 2022
HSF Asia-Pacific Competition Law Guide 2022 – now online
28 June 2022
More changes to come: China consults on amendments to six antitrust guidelines
Showing 12 out of 34 results
View moreKey contacts
Kyriakos Fountoukakos
Managing Partner, Competition/Antitrust, Regulation and Trade, Brussels
Veronica Roberts
Partner, Head of Competition/Antitrust, Regulation and Trade, UK, London
Linda Evans
Managing Partner, Competition Regulation and Trade, Asia and Australia, Sydney
Adelaide Luke
Partner, Head of Competition, Asia, Hong Kong
Jean Meijer
Managing Partner, Johannesburg Office, Johannesburg
Kristien Geeurickx
Knowledge Counsel, London